Hepatic metastases from breast cancer

Updates in Surgery

Volumn 62, Issue 3-4, 2010, Pages 143-148

  Rubino, Arianna ^a   Doci, Roberto ^a   Foteuh, Jean Claude ^a   Morenghi, Emanuela ^a   Fissi, Susanna ^b   Giorgetta, Casimiro ^b   Abumalouh, Islam ^a   Di Tommaso, Luca ^a   Gennari, Leandro ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b A MANZONI HOSPITAL   (Italy)

Author keywords

Breast; Liver metastases; Liver resection; Treatment

Indexed keywords

BREAST TUMOR; DISEASE FREE SURVIVAL; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; TUMOR RECURRENCE;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL;

EID: 80053355205     PISSN: 2038131X     EISSN: 20383312     Source Type: Journal    
DOI: 10.1007/s13304-010-0026-7     Document Type: Article

References (30)

1. Wingo PA, Tong T, Bolden S (1995) Cancer statistics. CA Cancer J Clin 45(1):8-30
2. Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170-1178 (Pubitemid 8312210)
3. Haagensen CD (1977) Treatment of curable carcinoma of the breast. J Radiol Oncol Biol Phys 2:975-980 (Pubitemid 8253106)
4. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JF, Evans AJ (2003) Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89:284-290 (Pubitemid 36976317)
5. Perez JE, Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Rodriguez R, Quevas MA, Alvarez LA (1990) Bone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. A GOCS study. Am J Clin Oncol 13:294-298 (Pubitemid 20262852)
6. Baur M, Schlappack O, Havelec L, Wrba F, Dittrich C (2001) Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer\a retrospective analysis. Acta Med Austriaca 28:135-140 (Pubitemid 35013559)
7. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271-278 (Pubitemid 30243049)
8. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J (1999) Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 56(1):67-78 (Pubitemid 29435816)
9. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F (2000) Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Rest Treat 59:177-184 (Pubitemid 30216141)
10. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guineb-retiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185:158-164 (Pubitemid 36143907)
11. Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, Makuuchi M (2005) Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 29:524-527 (Pubitemid 41125381)
12. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244:897-908
13. Pocard M, Pouillard P, Asselain B, Salmon R (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 26:155-159 (Pubitemid 30242938)
14. Thelen A, Benckert C, Jonas S, Lopez-Hänninen E, Sehouli J, Neumann U, Rudolph B, Neuhaus P (2008) Liver resection for metastases from breast cancer. J Surg Oncol 97:25-29
15. Lubrano J, Roman H, Tarrab S, Resch B, Marpeau L, Scotté M (2008) Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38:293-299 (Pubitemid 351661111)
16. Neri A, Marrelli D, Pedrazzani C, Caruso S, De Stefano A, Mariani F, Megha T, De Marco G, Corso G, Pinto E, Rovello F (2008) Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer. EJSO 34:1299-1303
17. Konecny GE, Thomssen C, Lück HJ, Unth M, Wang HJ, Kuhn W, Eidtmann H, du Bois A, Olbricht S, Steinfeld D, Mobus V, Von Minckwitz G, Dandekar S, Ramos L, Pauletti G, Pegram MD, Janicke F, Slamon DJ (2004) Her-2/neu gene amplification and response to paclitaxel in patients with metastastic breast cancer. J Natl Cancer Inst 96:1141-1151 (Pubitemid 39207050)
18. Gennari L, Doci R, Bozzetti F, Veronesi U (1982) Proposal for a clinical classification of liver metastases. Tumori 68:443-449 (Pubitemid 13166782)
19. Zhou P, Recht A (2004) Young age and outcome for women with early stage invasive breast carcinoma. Cancer 101(6):1264-1274 (Pubitemid 39180381)
20. Matthews R, McNeese M, Montague E, Oswald MJ (1988) Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or mastectomy. Int J Radiat Oncol Biol Phys 14:659-663
21. Eichbaum MH, Kaltwasser M, Bruckner T, de Rossi TM, Sch-neeweiss A, Sohn C (2006) Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 96:53-62
22. Martinez SR, Young SE, Giuliano AE, Bilchik AJ (2006) The utility of estrogen receptor, progesterone receptor and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg 191:281-283 (Pubitemid 43151282)
23. Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, Meric-Bernstam F, Lucci A (2009) HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res Treat 113(3):501-507
24. Ross DT, Kim CY, Tang G, Bohn OL, Beck RA, Ring BZ, Seitz RS, Paik S, Costantino JP, Wolmark N (2008) Chemosensitivity and stratification by a five monoclonal antibody immunohisto-chemistry test in the NSABP B14 and B20 trials. Clin Cancer Res 14:6602-6609
25. Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P (2005) Correlation of Her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Breast J 11:278-280 (Pubitemid 41026044)
26. Brown M, Tsodikov A, Bauer K, Parise CA, Caggiano V (2008) The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer. Cancer 112(4):737-747 (Pubitemid 351240567)
27. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonre-sectable colorectal [liver] metastases. Ann Surg Oncol 8:347-353 (Pubitemid 32422861)
28. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248(4):626-637
29. Yang SH, Yang KH, Li YP, Zhang YC, He XD, Song AL, Tian JH, Jiang L, Bai ZG, He LF, Liu YL, Ma B (2008) Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol 19(6):1039-1044 (Pubitemid 351796328)
30. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-1430